Nitric oxide synthase mediates cerebellar dysfunction in mice exposed to repetitive blast-induced mild traumatic brain injury

Sci Rep. 2020 Jun 10;10(1):9420. doi: 10.1038/s41598-020-66113-7.

Abstract

We investigated the role of nitric oxide synthase (NOS) in mediating blood-brain barrier (BBB) disruption and peripheral immune cell infiltration in the cerebellum following blast exposure. Repetitive, but not single blast exposure, induced delayed-onset BBB disruption (72 hours post-blast) in cerebellum. The NOS inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) administered after blast blocked BBB disruption and prevented CD4+ T-cell infiltration into cerebellum. L-NAME also blocked blast-induced increases in intercellular adhesion molecule-1 (ICAM-1), a molecule that plays a critical role in regulating blood-to-brain immune cell trafficking. Blocking NOS-mediated BBB dysfunction during this acute/subacute post-blast interval (24-71 hours after the last blast) also prevented sensorimotor impairment on a rotarod task 30 days later, long after L-NAME cleared the body. In postmortem brains from Veterans/military Servicemembers with blast-related TBI, we found marked Purkinje cell dendritic arbor structural abnormalities, which were comparable to neuropathologic findings in the blast-exposed mice. Taken collectively, these results indicate that blast provokes delayed-onset of NOS-dependent pathogenic cascades that can later emerge as behavioral dysfunction. These results also further implicate the cerebellum as a brain region vulnerable to blast-induced mTBI.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Blast Injuries / drug therapy
  • Blast Injuries / metabolism*
  • Blast Injuries / physiopathology*
  • Blood-Brain Barrier / metabolism
  • Blood-Brain Barrier / physiopathology
  • Brain Concussion / drug therapy
  • Brain Concussion / metabolism
  • Brain Concussion / physiopathology*
  • Cerebellar Diseases / drug therapy
  • Cerebellar Diseases / metabolism*
  • Cerebellar Diseases / physiopathology*
  • Cerebellum / drug effects
  • Cerebellum / metabolism
  • Cerebellum / physiopathology*
  • Disease Models, Animal
  • Intercellular Adhesion Molecule-1 / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase / metabolism*
  • Purkinje Cells / drug effects
  • Purkinje Cells / metabolism
  • Purkinje Cells / pathology

Substances

  • Intercellular Adhesion Molecule-1
  • Nitric Oxide Synthase
  • NG-Nitroarginine Methyl Ester